Formoterol Fumarate Patent Expiration
Formoterol Fumarate is Used for managing symptoms and improving lung function in individuals with chronic obstructive pulmonary disease. It was first introduced by Novartis Pharmaceuticals Corp
Formoterol Fumarate Patents
Given below is the list of patents protecting Formoterol Fumarate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Perforomist | US6667344 | Bronchodilating compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Perforomist | US6814953 | Bronchodilating compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Perforomist | US7348362 | Bronchodilating β-agonist compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Perforomist | US7462645 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Perforomist | US8623922 | Bronchodilating Beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Perforomist | US9730890 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Mylan Speclt |
| Foradil | US6887459 | Aerosol composition comprising formoterol |
Nov 28, 2020
(Expired) | Novartis |
| Foradil | US6488027 | Powder inhaler |
Mar 08, 2019
(Expired) | Novartis |
Formoterol Fumarate's Family Patents
Explore Our Curated Drug Screens
Formoterol Fumarate Generic API Manufacturers
Several generic applications have been filed for Formoterol Fumarate. The first generic version for Formoterol Fumarate was by Teva Pharmaceuticals Usa Inc and was approved on Jun 22, 2021. And the latest generic version is by Lexenpharm Suzhou Ltd and was approved on Oct 22, 2024.
Given below is the list of companies who have filed for Formoterol Fumarate generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Nov 22, 2021 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
2. LEXENPHARM
Lexenpharm Suzhou Ltd has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Lexenpharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Oct 22, 2024 |
3. LUPIN
Lupin Inc has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Lupin.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Aug 22, 2022 |
Manufacturing Plant Locations New
Lupin's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Lupin as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||||||||
4. MANKIND PHARMA
Mankind Pharma Ltd has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Mar 22, 2023 |
Manufacturing Plant Locations New
Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
5. MICRO LABS
Micro Labs Ltd has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Micro Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Jun 26, 2024 |
Manufacturing Plant Locations New
Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
6. RITEDOSE CORP
The Ritedose Corp has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Ritedose Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Nov 25, 2022 |
7. TEVA PHARMS USA INC
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Jun 22, 2021 |
8. WILSHIRE PHARMS INC
Wilshire Pharmaceuticals Inc has filed for 1 generic for Formoterol Fumarate. Given below are the details of the strengths of this generic introduced by Wilshire Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/2ML | solution | Prescription | INHALATION | AN | Dec 13, 2022 |